<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04839445</url>
  </required_header>
  <id_info>
    <org_study_id>2909</org_study_id>
    <nct_id>NCT04839445</nct_id>
  </id_info>
  <brief_title>ESP vs TAP in Total Laparoscopic Hysterectomy</brief_title>
  <acronym>ARTEMIDE</acronym>
  <official_title>Comparison of Efficacy of Ultrasound-guided Erector Spinae Place Block Versus Transversus Abdominis Plane Block for Intra and Postoperative Pain Control in Total Laparoscopic Hysterectomy: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AUSL Romagna Rimini</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AUSL Romagna Rimini</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The anesthetic techniques for videolaparoscopic surgery include general anesthesia, and&#xD;
      locoregional anesthesia in association with general anesthesia in order to reduce or abolish&#xD;
      post-operative pain with a simultaneous reduction in the use of opioids and days of hospital&#xD;
      stay.&#xD;
&#xD;
      From the studies published so far on videolaparoscopic surgery in general, it is clear that&#xD;
      the transversus abdominal plane (TAP) block could have a role in reducing the stretch wall&#xD;
      pain secondary to pneumoperitoneum and incisional, although its role in this regard is not&#xD;
      yet clear, nor significant statistically results have been produced. The use of erector&#xD;
      spinae plane (ESP) block for the management of visceral pain is finding more and more space&#xD;
      in the literature, with promising results.&#xD;
&#xD;
      For videolaparoscopic gynecological surgery, the techniques of locoregional anesthesia&#xD;
      studied in association with general anesthesia, up to now, include wall blocks, TAP block and&#xD;
      ESP block, while neuraxial anesthesia has no indications in this regard.&#xD;
&#xD;
      Although videolaparoscopic hysterectomy is considered less painful than the open-abdomen&#xD;
      technique, it requires careful management of post-operative pain. The pain of this surgery is&#xD;
      the result of the sum of incisional pain, at the insertion points of the laparoscopic&#xD;
      trocars, pain due to pneumoperitoneum usually referred to the shoulder, and visceral pain&#xD;
      purely dependent on surgical maneuvers. There is currently no strong evidence to support the&#xD;
      use of locoregional anesthesia techniques in videolaparoscopic gynecological surgery. Few&#xD;
      studies have been produced about this topic, and they are mostly case series or randomized&#xD;
      controlled trials that take into consideration only one technique among those possible. To&#xD;
      date, no study compares the various techniques to evaluate the possible superiority of one&#xD;
      over the other.&#xD;
&#xD;
      In our hospital anesthesists carry out, in normal clinical practice, all the aforementioned&#xD;
      local anesthesia techniques.&#xD;
&#xD;
      The purpose of our work is to evaluate, with a randomized non-sponsored study, the efficacy&#xD;
      of the ESP block and the TAP block for intra and post-operative pain control in&#xD;
      videolaparoscopic hysterectomy, and to compare the two techniques.&#xD;
&#xD;
      Based on the evidence available in the literature, the two techniques are already part of the&#xD;
      current clinical practice of the Anesthesia Unit of our hospital and the choice of one&#xD;
      technique over the other is based on anesthetist clinical evaluation to date. The&#xD;
      anesthetists involved in the study are adequately trained on both anesthetic procedures.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 22, 2021</start_date>
  <completion_date type="Anticipated">March 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative pain control</measure>
    <time_frame>12 hours</time_frame>
    <description>Evaluate the difference between the two groups regarding post-operative pain using Numeric Rating Scale (NRS) 0= better outcome; 10=worse outcome Score will be measured on the numeric rating scale (NRS), an NRS â‰¤ 4 will be considered as effective antalgic coverage.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intra operative use of opioids.</measure>
    <time_frame>Surgery time.</time_frame>
    <description>Mcg of Remifentanil consumed during surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative use of non-steroidal anti-inflammatory drugs</measure>
    <time_frame>2-6-12-24-36 postoperative hours</time_frame>
    <description>Mg of ketorolac or any others anti-inflammatory drugs administered after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative use of opioids</measure>
    <time_frame>2-6-12-24-36 postoperative hours</time_frame>
    <description>Mg of opioids administered after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and / or vomiting</measure>
    <time_frame>2-6-12-24-36 postoperative hours</time_frame>
    <description>Quantity of antiemetic drugs required to control nausea and vomiting episodes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Days of hospital stay</measure>
    <time_frame>3 days</time_frame>
    <description>The number of days of hospitalization after surgery will be assessed</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of patient satisfaction with the anesthesiological technique</measure>
    <time_frame>36 hours</time_frame>
    <description>Patients is requested to fill out a pre-printed sheet on their judgment of the anesthesiological procedure, in which they can express a value from 0 to 5, where 0 indicates &quot;entirely dissatisfied&quot; and 5 indi- cates &quot;very satisfied&quot;expressed by the patient according to the following scale: satisfied, very satisfied, not at all satisfied</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Anesthesia</condition>
  <condition>Gynecologic Cancer</condition>
  <arm_group>
    <arm_group_label>General anesthesia + TAP block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Induction: remifentanil in total intravenous anesthesia (TIVA), Propofol 2 mg/kg/h and Rocuronium 0.6 mg/kg. Transversus abdominis plane (TAP) block: 20 minutes before surgery. Ropivacaine 0.37% 20ml + dexamethasone 2mg per side. Maintenance: TIVA with Propofol, the infusion rate will be adjusted according to the bispectral index system (BIS) values (30 &lt;BIS &lt;50). Patients will receive additional remifentanil by infusion at 0.02 mcg/kg/min per time if blood pressure and heart rate values exceed 20% pre-operative baseline values. Additional rocuronium 0.1 mg/kg based on clinical needs and train of four (TOF) monitoring. Analgesic starter bolus: 30 minutes before the end of the surgery, paracetamol 1 gr ev and ketorolac 30 mg ev. Postoperative pain: paracetamol 1 gr ev every 8 hours for 36 hours; ketorolac 30 mg ev if NRS &gt;4 / morphine 2 mg ev if NRS &gt;4 30 min after ketorolac administration. In case of nausea and vomiting ondansetron 4 mg ev.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General anesthesia + ESP block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Erector spinae plane (ESP) block: 20 minutes before surgery. T8 level bilaterally, ropivacaine 0.37% 20ml + dexamethasone 2mg per side.&#xD;
Induction: Remifentanil in TIVA, Propofol 2 mg/kg/h and Rocuronium 0.6 mg/kg. Maintenance: TIVA with Propofol, the infusion rate will be adjusted according to the BIS values (30 &lt;BIS &lt;50). Patients will receive additional remifentanil by infusion at 0.02 mcg/kg/min per time if blood pressure and heart rate values exceed 20% pre-operative baseline values. Additional rocuronium 0.1 mg/kg based on clinical needs and TOF monitoring.&#xD;
Analgesic starter bolus: 30 minutes before the end of the surgery, paracetamol 1 gr ev and ketorolac 30 mg ev.&#xD;
Postoperative pain: paracetamol 1 gr ev every 8 hours for 36 hours; ketorolac 30 mg ev if NRS &gt;4 / morphine 2 mg ev if NRS &gt;4 30 min after ketorolac administration. In case of nausea and vomiting ondansetron 4 mg ev.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General anesthesia + TAP block</intervention_name>
    <description>Post induction TAP block for intra and postoperative analgesia.</description>
    <arm_group_label>General anesthesia + TAP block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General anesthesia + ESP block</intervention_name>
    <description>Pre induction ESP block for intra and postoperative analgesia.</description>
    <arm_group_label>General anesthesia + ESP block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  American society of anesthesiologists (ASA) I-III risk&#xD;
&#xD;
          -  no contraindication to the execution of the peripheral nerve block&#xD;
&#xD;
          -  signature of the informed consent&#xD;
&#xD;
          -  total videolaparoscopic surgery (no conversion to open-abdomen)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  allergies and / or contraindications to the administration of the drugs used in the&#xD;
             study&#xD;
&#xD;
          -  infections and injuries at the puncture site&#xD;
&#xD;
          -  BMI â‰¥40&#xD;
&#xD;
          -  history of opioid abuse or use of opioids in chronic therapy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chiara Rosato, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>AUSL Romagna</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chiara Rosato, MD</last_name>
    <phone>3883527120</phone>
    <phone_ext>+39</phone_ext>
    <email>chiara.rosato@auslromagna.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Domenico Santonastaso, MD</last_name>
    <email>domenicopietro.santonastaso@auslromagna.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AUSL Romagna M. Bufalini Hospital</name>
      <address>
        <city>Cesena</city>
        <state>Emilia Romagna</state>
        <zip>47521</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Domenico Pietro Santonastaso, MD</last_name>
      <phone>0547352818</phone>
      <email>domenicopietro.santonastaso@auslromagna.it</email>
    </contact>
    <investigator>
      <last_name>Domenico Pietro Santonastaso, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <results_reference>
    <citation>Jones JH, Aldwinckle R. Interfascial Plane Blocks and Laparoscopic Abdominal Surgery: A Narrative Review. Local Reg Anesth. 2020 Oct 23;13:159-169. doi: 10.2147/LRA.S272694. eCollection 2020. Review.</citation>
    <PMID>33122942</PMID>
  </results_reference>
  <results_reference>
    <citation>Bagaphou CT, Santonastaso DP, Rispoli M, Piraccini E, Fusco P, Gori F. Bilateral continuous erector spinae plane block: an alternative to epidural catheter for major open abdominal surgery. Minerva Anestesiol. 2020 Sep;86(9):993-994. doi: 10.23736/S0375-9393.20.14557-7. Epub 2020 Jun 2.</citation>
    <PMID>32490608</PMID>
  </results_reference>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 5, 2021</study_first_submitted>
  <study_first_submitted_qc>April 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2021</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Transversus Abdominal Plane Block</keyword>
  <keyword>Erector Spinae Plane Block</keyword>
  <keyword>General Anesthesia</keyword>
  <keyword>Laparoscopic Hysterectomy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

